Nx GEN SEQUENCING OPHTHALMOPLEGIA Test
Welcome to DNA Labs UAE, where we offer the Nx GEN SEQUENCING OPHTHALMOPLEGIA Test. This test is designed to diagnose ophthalmoplegia, a condition that affects the muscles controlling eye movement.
Test Details
The Nx Gen Sequencing is a type of genetic testing that can be used to diagnose ophthalmoplegia. It involves analyzing the DNA of an individual to identify any genetic mutations that may be causing the condition.
Components
- C10orf2
- DNA2
- OPA1
- POLG
- POLG2
- RRM2B
- SLC25A4
- TYMP
Price
The cost of the Nx GEN SEQUENCING OPHTHALMOPLEGIA Test is 5730.0 AED.
Sample Condition
To conduct the test, please submit 10 mL (5 mL min.) of whole blood from 2 Lavender Top (EDTA) tubes. The sample should be shipped refrigerated and should not be frozen. Additionally, a duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.
Report Delivery
The sample should be submitted daily by 9 am, and the report will be delivered within 45 working days.
Method
The Nx GEN SEQUENCING OPHTHALMOPLEGIA Test utilizes NGS (Next-Generation Sequencing) and Sanger sequencing methods.
Test Type
This test is specifically designed to diagnose weakness of eye muscles and is performed by an Ophthalmologist.
Test Department
The Nx GEN SEQUENCING OPHTHALMOPLEGIA Test is conducted in our Molecular Diagnostics department.
Pre Test Information
A duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory before conducting the test.
About Ophthalmoplegia and Genetic Testing
Ophthalmoplegia is a condition that affects the muscles responsible for eye movement, resulting in difficulty moving the eyes in different directions. Nx Gen Sequencing is a type of genetic testing that can be used to diagnose ophthalmoplegia. This testing method involves analyzing an individual’s DNA to identify any genetic mutations that may be causing the condition.
Nx Gen Sequencing is particularly useful for individuals with a family history of ophthalmoplegia or those with symptoms suggesting a genetic cause for their condition. The test requires a sample of the individual’s DNA, typically obtained through a blood or saliva sample. The DNA is then sequenced to identify any mutations or changes in the genetic code that may be contributing to the ophthalmoplegia.
Once the genetic mutations have been identified, the results can be used to help diagnose the condition and determine the best course of treatment. In some cases, genetic testing may also be used to identify other family members who may be at risk of developing ophthalmoplegia due to the same genetic mutation.
At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. If you suspect ophthalmoplegia or have a family history of the condition, our Nx GEN SEQUENCING OPHTHALMOPLEGIA Test can provide valuable insights into your genetic makeup and guide your treatment options.
| Test Name | Nx GEN SEQUENCING OPHTHALMOPLEGIA Test |
|---|---|
| Components | C10orf2, DNA2, OPA1, POLG, POLG2, RRM2B, SLC25A4, TYMP |
| Price | 5730.0 AED |
| Sample Condition | Submit 10 mL (5 mL min.) whole blood from 2 Lavender Top (EDTA) tubes. Ship refrigerated. DO NOT FREEZE. Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory. |
| Report Delivery | Sample Daily by 9 am; Report 45 Working days |
| Method | NGS, Sanger sequencing |
| Test type | Weakness of Eye muscles |
| Doctor | Ophthalmologist |
| Test Department: | MOLECULAR DIAGNOSTICS |
| Pre Test Information | Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory. |
| Test Details | Nx Gen Sequencing is a type of genetic testing that can be used to diagnose ophthalmoplegia. Ophthalmoplegia is a condition that affects the muscles that control eye movement, resulting in difficulty moving the eyes in different directions. Nx Gen Sequencing involves analyzing the DNA of an individual to identify any genetic mutations that may be causing the ophthalmoplegia. This type of testing can be particularly useful for individuals who have a family history of ophthalmoplegia or who have other symptoms that suggest a genetic cause for their condition. The test involves taking a sample of the individual’s DNA, typically through a blood or saliva sample. The DNA is then sequenced, or read, to identify any mutations or changes in the genetic code that may be contributing to the ophthalmoplegia. Once the genetic mutations have been identified, the results can be used to help diagnose the condition and determine the best course of treatment. In some cases, genetic testing may also be used to identify other family members who may be at risk for developing ophthalmoplegia due to the same genetic mutation. |
